These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24755237)
1. Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus. Leinonen V; Rinne JO; Wong DF; Wolk DA; Trojanowski JQ; Sherwin PF; Smith A; Heurling K; Su M; Grachev ID Acta Neuropathol Commun; 2014 Apr; 2():46. PubMed ID: 24755237 [TBL] [Abstract][Full Text] [Related]
2. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137 [TBL] [Abstract][Full Text] [Related]
3. An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Wong DF; Moghekar AR; Rigamonti D; Brašić JR; Rousset O; Willis W; Buckley C; Smith A; Gok B; Sherwin P; Grachev ID Mol Imaging Biol; 2013 Apr; 15(2):230-7. PubMed ID: 22878921 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients. Leinonen V; Rinne JO; Virtanen KA; Eskola O; Rummukainen J; Huttunen J; von Und Zu Fraunberg M; Nerg O; Koivisto AM; Rinne J; Jääskeläinen JE; Buckley C; Smith A; Jones PA; Sherwin P; Farrar G; McLain R; Kailajärvi M; Heurling K; Grachev ID Eur J Neurol; 2013 Jul; 20(7):1043-52. PubMed ID: 23398333 [TBL] [Abstract][Full Text] [Related]
5. Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus. Rinne JO; Frantzen J; Leinonen V; Lonnrot K; Laakso A; Virtanen KA; Solin O; Kotkansalo A; Koivisto A; Sajanti J; Karppinen A; Lehto H; Rummukainen J; Buckley C; Smith A; Jones PA; Sherwin P; Farrar G; McLain R; Kailajarvi M; Grachev ID Neurodegener Dis; 2014; 13(4):237-45. PubMed ID: 24296542 [TBL] [Abstract][Full Text] [Related]
6. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124 [TBL] [Abstract][Full Text] [Related]
7. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Wolk DA; Grachev ID; Buckley C; Kazi H; Grady MS; Trojanowski JQ; Hamilton RH; Sherwin P; McLain R; Arnold SE Arch Neurol; 2011 Nov; 68(11):1398-403. PubMed ID: 21747004 [TBL] [Abstract][Full Text] [Related]
8. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease. Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias. Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593 [TBL] [Abstract][Full Text] [Related]
10. Estimation of amyloid distribution by [ Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935 [TBL] [Abstract][Full Text] [Related]
11. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies. Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068 [TBL] [Abstract][Full Text] [Related]
12. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104 [TBL] [Abstract][Full Text] [Related]
13. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans. Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776 [TBL] [Abstract][Full Text] [Related]
14. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679 [TBL] [Abstract][Full Text] [Related]
15. Temporal and anatomical distribution of Yun T; Lee W; Kang JH; Yang MP; Kang BT BMC Vet Res; 2020 Jan; 16(1):17. PubMed ID: 31952531 [TBL] [Abstract][Full Text] [Related]
16. [(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology. Thal DR; Beach TG; Zanette M; Heurling K; Chakrabarty A; Ismail A; Smith AP; Buckley C Alzheimers Dement; 2015 Aug; 11(8):975-85. PubMed ID: 26141264 [TBL] [Abstract][Full Text] [Related]
17. Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load. Leuzy A; Lilja J; Buckley CJ; Ossenkoppele R; Palmqvist S; Battle M; Farrar G; Thal DR; Janelidze S; Stomrud E; Strandberg O; Smith R; Hansson O Neurology; 2020 Nov; 95(21):e2834-e2844. PubMed ID: 33077542 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658 [TBL] [Abstract][Full Text] [Related]
19. Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus. Hiraoka K; Narita W; Kikuchi H; Baba T; Kanno S; Iizuka O; Tashiro M; Furumoto S; Okamura N; Furukawa K; Arai H; Iwata R; Mori E; Yanai K J Neurol Sci; 2015 Sep; 356(1-2):124-8. PubMed ID: 26095458 [TBL] [Abstract][Full Text] [Related]
20. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease. Hatashita S; Yamasaki H; Suzuki Y; Tanaka K; Wakebe D; Hayakawa H Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):290-300. PubMed ID: 24085503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]